DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

10272	Companies
212497	Keywords
142291	Articles
112519	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 07/30/2024 at 22:30, 1 year 8 months ago

DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
DBV Technologies provides updates on Viaskin Peanut Program for children and toddlers, reports Q2 and half-year 2024 financial results. Read about VITESSE and COMFORT Toddlers trials and cost-saving measures extending cash runway

Financial Results Children DBV Technologies Viaskin Peanut Toddler
BRIEF

published on 07/29/2024 at 07:35, 1 year 8 months ago

DBV Technologies to Announce Q2 2024 Financial Results

Webcast Financial Update DBV Technologies Q2 2024 Results Viaskin Platform
PRESS RELEASE

published on 07/29/2024 at 07:30, 1 year 8 months ago

DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
DBV Technologies to host conference call and webcast to review second quarter 2024 financial results and business update on July 30, 2024. Focus on food allergy treatments

Financial Results Conference Call Immunotherapy DBV Technologies Food Allergies
BRIEF

published on 07/08/2024 at 22:35, 1 year 9 months ago

Half-yearly review of the DBV Technologies liquidity contract with ODDO BHF

Liquidity Contract ODDO BHF Stock Transactions DBV Technologies Half-yearly Review
PRESS RELEASE

published on 07/08/2024 at 22:30, 1 year 9 months ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
DBV Technologies issues Half-Year Report on Liquidity Contract with ODDO BHF, revealing assets and transaction details for the period

Liquidity Contract Transactions Half-year Report ODDO BHF DBV Technologies
BRIEF

published on 06/05/2024 at 22:35, 1 year 10 months ago

DBV Technologies to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Investors DBV Technologies Viaskin Goldman Sachs Global Healthcare Conference Daniel Tassé
PRESS RELEASE

published on 06/05/2024 at 22:30, 1 year 10 months ago

DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
DBV Technologies to participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10th, featuring CEO Daniel Tassé in a fireside chat and investor meetings. Live webcast available online

Biopharmaceutical DBV Technologies Food Allergies Goldman Sachs Global Healthcare Conference Daniel Tassé
BRIEF

published on 06/04/2024 at 22:35, 1 year 10 months ago

DBV Technologies Reports Voting Rights and Shares Information as of May 31, 2024

Voting Rights Shares AMF Regulations DBV Technologies
PRESS RELEASE

published on 06/04/2024 at 22:30, 1 year 10 months ago

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
Press release providing information on the total number of voting rights and shares of the Company as of May 31, 2024, in compliance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers

Voting Rights Shares AMF Company NYSE Euronext Paris
BRIEF

published on 05/31/2024 at 15:56, 1 year 10 months ago

DBV Technologies Announces Plan to Implement ADS Ratio Change

Nasdaq Compliance Biopharmaceutical Reverse Split DBV Technologies ADS Ratio

Accesswire

Published on 04/23/2026 at 15:00, 37 minutes ago

Critical Elements Announces the Results from The Annual Meeting of Shareholders
Published on 04/23/2026 at 14:30, 1 hour 7 minutes ago

Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:30, 1 hour 7 minutes ago

Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Published on 04/23/2026 at 14:00, 1 hour 37 minutes ago

Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Published on 04/23/2026 at 14:00, 1 hour 37 minutes ago

PPX Mining Provides Exploration Plan for 2026

View all ACCESSWIRE

EQS Group

Published on 04/23/2026 at 15:17, 20 minutes ago

EQS-Adhoc: Gateway Real Estate AG is postponing the publication of its 2025 consolidated financial statements
Published on 04/23/2026 at 15:10, 26 minutes ago

Newron announces AGM 2026 results
Published on 04/23/2026 at 15:07, 29 minutes ago

Resolutions of the 82nd Annual General Meeting of Lenzing Group
Published on 04/23/2026 at 15:00, 37 minutes ago

Medartis shareholders endorse Board proposals with strong support at AGM 2026
Published on 04/23/2026 at 14:05, 1 hour 32 minutes ago

FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION

Les Echos

Published on 04/23/2026 at 14:30, 1 hour 7 minutes ago

KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV
Published on 04/23/2026 at 08:00, 7 hours 37 minutes ago

Mersen Signs A Contract with Vulcan Energy as part of Europe’s Battery industry initiative
Published on 04/23/2026 at 07:00, 8 hours 37 minutes ago

bioMérieux – First-Quarter 2026 Business Review
Published on 04/23/2026 at 07:00, 8 hours 37 minutes ago

Safran reports first quarter 2026 revenue
Published on 04/23/2026 at 07:00, 8 hours 37 minutes ago

Edenred records sustained growth in Q1 and confirms its objectives for 2026 and beyond

View all LES ECHOS COMFI WIRE